13th International Conference of the Society of Integrative Oncology

The following five abstracts were chosen as the best submitted studies presented at this year’s International Conference of the Society for Integrative Oncology (SIO). They represent a diverse group o...

Integrative Oncology

Jo Cavallo / December 25, 2016 / 13th International Conference of the Society of Integrative Oncology

Advancing the Global Impact of Integrative Oncology

The 13th International Conference of the Society of Integrative Oncology (SIO) held in Miami, Florida, in November, drew its largest audience yet, with nearly 400 clinicians, researchers, patients, a...

Nov

Today In Oncology

Undertreatment of High-Risk Prostate Cancer in Latino Men

Azacitidine Plus Nivolumab in Relapsed or Refractory AML

Neoadjuvant Chemotherapy vs Upfront Debulking Surgery in Advanced Tubo-Ovarian Cancer

Multimodality Therapy and Lateral Local Recurrence in Rectal Cancer

Treatment With ADT May Be Linked to Higher Risk of Heart Failure in Patients With Prostate Cancer

;

13th International Conference of the Society of Integrative Oncology

The Best of SIO

Advancing the Global Impact of Integrative Oncology

Undertreatment of High-Risk Prostate Cancer in Latino Men

Azacitidine Plus Nivolumab in Relapsed or Refractory AML

Neoadjuvant Chemotherapy vs Upfront Debulking Surgery in Advanced Tubo-Ovarian Cancer

Multimodality Therapy and Lateral Local Recurrence in Rectal Cancer

Treatment With ADT May Be Linked to Higher Risk of Heart Failure in Patients With Prostate Cancer

Weighing the Cost and Value of CAR T-Cell Therapy

FDA Pipeline: What’s New in Biosimilars, Drug Reviews, Designations, and More

Immunotherapy Improves Survival in a Subset of Patients With Metastatic Triple-Negative Breast Cancer

FDA Expands Approved Use of Brentuximab Vedotin in Some Types of PTCL

A Gleason 6 Tumor: Is It Cancer, and Should It Be Treated?

Howard M. Sandler, MD, on Prostate Cancer: Prospective Trials Update

Matthew J. Ellis, MB, BChir, PhD, on Breast Cancer: Neoadjuvant Endocrine Therapy

Johan F. Vansteenkiste, MD, PhD, on NSCLC: Immunotherapy and Targeted Treatments

Suresh S. Ramalingam, MD, on Lung Cancer: Research Highlights

Ezra E.W. Cohen, MD, on Head and Neck Cancer: Using Curative Immunotherapy